A Large Vaccine‐Derived Poliovirus Outbreak on Madura Island—Indonesia, 2005
Author(s) -
Concepción F. Estívariz,
Margaret A. Watkins,
Darmawali Handoko,
Rusipah Rusipah,
Jagadish M. Deshpande,
Bardan Rana,
Eveline Irawan,
Dyah Widhiastuti,
Mark A Pallansch,
Arun Thapa,
Sholah Imari
Publication year - 2008
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/525049
Subject(s) - virology , poliovirus , vaccination , outbreak , herd immunity , immunization , poliomyelitis , medicine , attack rate , population , epidemiology , environmental health , immunology , virus , antibody
Between June and October 2005, 45 laboratory-confirmed type 1 vaccine-derived poliovirus (VDPV) cases were identified on Madura Island in Indonesia. Genetic sequencing data on VDPV isolates were consistent with replication and circulation for up to approximately 2 years. Concurrent circulation with type 1 wild poliovirus (WPV) enabled comparisons of VDPV and WPV cases and found that clinical and epidemiological features of both were similar. Attack rates for VDPV were as high as those for WPV. Of 41 VDPV case patients with known vaccination status, 25 (61%) had received zero oral polio vaccine (OPV) doses. Low population immunity due to low routine OPV coverage in rural areas and the absence of WPV circulation for more than a decade were major predisposing factors for the emergence of VDPV. Suboptimal surveillance and a limited initial immunization response may have contributed to widespread circulation. Sensitive surveillance and prompt high-quality immunization responses are recommended to prevent the spread of VDPVs.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom